✅ Model Answer:
• Diagnosis: β-thalassemia trait (β-thalassemia minor) — microcytic anemia (MCV 68 fL) with normal RDW (14%), normal iron studies (ferritin 85, iron 70, TIBC 320), and elevated HbA2 (5.2% >3.5%). HbF is normal (1.5%). Mild fatigue is consistent with this condition.
• Any other test: Hb electrophoresis of parents (for genetic counseling), complete blood count of family members (to identify carriers), α-globin gene testing (if HbA2 normal but microcytosis persists to rule out α-thalassemia trait).
• What to do next: Reassurance; no iron therapy needed (iron deficiency is not present). Genetic counseling for the family: if both parents are carriers, there is a 25% risk of thalassemia major in each pregnancy. Refer for prenatal diagnosis if indicated.
• Follow-up plan: Monitor Hb annually. If planning pregnancy, partner should be tested for β-thalassemia trait. No specific treatment is required. Folic acid supplementation is not needed unless there is concurrent hemolysis.

✅ Model Answer:
• β-thalassemia trait is a heterozygous state for a β-globin gene mutation, resulting in reduced β-globin chain production.
• Genetics: Autosomal recessive inheritance — one normal β-globin gene and one mutated gene.
• HbA2 elevation: Compensatory increase in HbA2 (δ-globin chains) to >3.5% (hallmark of β-thalassemia trait).
• Clinical features: Usually asymptomatic or mild fatigue. Mild microcytic anemia (Hb 10-12 g/dL, MCV 60-75 fL).
• No treatment needed: Iron therapy is NOT indicated (ferritin is normal).
• Risk: If both parents have β-thalassemia trait, each child has 25% risk of β-thalassemia major (transfusion-dependent).

✅ Model Answer:
• Key differentiating features:
- Ferritin: Normal in β-thalassemia trait; low in iron deficiency anemia
- Iron studies: Normal in β-thalassemia trait; low serum iron, high TIBC in iron deficiency
- RDW: Normal in β-thalassemia trait; elevated in iron deficiency
- HbA2: Elevated (>3.5%) in β-thalassemia trait; normal in iron deficiency
- RBC count: Often elevated (>5.0 × 10⁶/µL) in β-thalassemia trait; low in iron deficiency
- Mentzer index: MCV/RBC ratio <13 suggests β-thalassemia trait; >13 suggests iron deficiency
- Response to iron: No response in β-thalassemia trait; Hb rises in iron deficiency
• Clinical pearl: Do NOT treat β-thalassemia trait with iron — iron overload can occur if given unnecessarily.

✅ Model Answer:
• Gene: HBB gene located on chromosome 11p15.5.
• Mutations: >200 mutations identified (point mutations, deletions, insertions).
• Common mutations: IVS-I-110 (G>A), IVS-I-6 (T>C), IVS-II-1 (G>A), codon 39 (C>T), codon 8/9 (+G).
• Inheritance: Autosomal recessive (both parents must be carriers for a child to have β-thalassemia major).
• Types:
- β⁰: No β-globin chain production (severe thalassemia major)
- β⁺: Reduced β-globin chain production (milder thalassemia intermedia/major)
- Silent carrier: Very mild or no anemia (HbA2 may be borderline)

✅ Model Answer:
• Indications for genetic counseling:
- Both parents are carriers: 25% risk of thalassemia major in each pregnancy — offer prenatal diagnosis (chorionic villus sampling or amniocentesis).
- Family planning: If a carrier is planning pregnancy, partner should be tested for β-thalassemia trait.
- At-risk relatives: Siblings and other family members should be offered carrier screening.
- Ethnic populations: Mediterranean, Middle Eastern, South Asian, and Southeast Asian populations have higher carrier rates.
- Pre-conception counseling: For couples at risk to discuss options: prenatal diagnosis, preimplantation genetic diagnosis, or adoption.
- Education: Inform the family about the condition, inheritance pattern, and lack of symptoms in carriers.

✅ Model Answer:
• Hb electrophoresis separates hemoglobin fractions by charge and quantifies HbA, HbA2, HbF, and variant hemoglobins (HbS, HbC, HbE, etc.).
• Normal adult pattern: HbA 95-98%, HbA2 1.5-3.5%, HbF <2%.
• β-thalassemia trait: HbA2 >3.5% (often 4-7%), HbF may be normal or slightly elevated, HbA reduced.
• β-thalassemia major: HbF 90-100%, HbA absent or very low, HbA2 variable.
• β-thalassemia intermedia: Variable HbF (20-80%), HbA 20-80%.
• α-thalassemia trait: HbA2 is normal (usually <3.5%) — requires genetic testing.
• HbS trait: HbA 50-60%, HbS 35-45%.
• HbE trait: HbE 25-35%, HbA 60-70%.

✅ Model Answer:
• Complications of β-thalassemia trait:
- Usually none — most individuals are asymptomatic.
- Mild anemia: May cause mild fatigue, especially during pregnancy or periods of increased demand.
- Misdiagnosis: Often mistaken for iron deficiency anemia → inappropriate iron supplementation → iron overload (rare but possible).
- Pregnancy: May exacerbate anemia; requires monitoring of Hb and iron studies.
- Co-inheritance: If combined with other hemoglobinopathies (HbS, HbE), may affect phenotype (e.g., sickle β-thalassemia).
- Splenomegaly: Rare but can occur (usually mild).
- Gallstones: Slightly increased risk (due to mild hemolysis).
- No effect on life expectancy.

✅ Model Answer:
• Prognosis:
- Excellent — β-thalassemia trait is a benign condition with no significant morbidity or mortality.
- Life expectancy: Normal.
- No treatment required.
• Long-term outcomes:
- No iron therapy: Iron supplementation is NOT indicated unless iron deficiency is confirmed (ferritin low).
- Annual monitoring: Routine CBC and ferritin every 1-2 years (or if symptomatic).
- Pregnancy: If planning pregnancy, partner should be tested for β-thalassemia trait.
- Genetic counseling: Offer to family members at risk.
- Education: Reassure the child and family about the benign nature of the condition.
- Blood donation: Hb may be too low for blood donation (depending on the threshold).